†These authors contributed equally.
Academic Editor: Shigeki Matsubara
Background: To
evaluate the efficacy and safety of
carbetocin compared with oxytocin for prevention of
postpartum hemorrhage (PPH) after elective
cesarean section in Chinese high risk women. Methods: This was a
single-center, prospective, randomized, open-label, controlled trial recruiting
852 pregnant women with one or more PPH risk factors between
April 2017 and August 2019. Pregnant woman who was scheduled for an elective
cesarean section were randomly assigned to receive carbetocin or oxytocin for
prevention of PPH. The primary efficacy endpoint was the proportion of additional
uterotonics. Results: A total of 852 pregnant women were
randomly assigned to receive carbetocin (n = 442) or oxytocin (n = 410). The
baseline characteristics were comparable between the two groups.
The carbetocin group had lower proportion of requiring
additional uterotonics (18.4% vs. 24.4%, p = 0.03 in full analysis set
[FAS] analysis) to the oxytocin group. The amount of blood loss (intrapartum or
postpartum) was no statistically significant difference (all p